Early- and late-stage morphea subtypes with deep tissue involvement is treatable with Abatacept (Orencia)

We present three cases, one with exceptionally severe disease, which demonstrated excellent clinical response to Abatacept. Abatacept is a promising option for the treatment of severe or resistant morphea, especially in those with deep tissue involvement.